NRasG12D and EZH2-deficiency-induced leukemia presents important features that recapitulate human AML with preceding preleukemic conditions, including the presence of an indolent MPN phase and the disease course over an extended period of time. This evidence concerns the gene EZH2 and myeloproliferative disorder.